Disneys Star Wars The Mandalorian and Grogu Opens to RecordLow Thursday Previews in Franchise History Speculation Surfaces Could SpaceX Intel Merge in a 1 Trillion Deal Supertanker with Iraqi Crude Departs Persian Gulf as USIran Talks Progress JPMorgans Summer Reading List for Affluent Clients Highlights AI Leadership and Unexpected Titles New York Fed Study Reveals Surging Gas Prices Disproportionately Impact LowerIncome Households Boeings LongTerm Trajectory Analyst Perspectives on the Next Decade HOVR Q1 2026 Earnings EPS Misses Estimates Despite Stock Surge HealthEquity Q1 2026 Earnings EPS Beats Estimates Stock Rises 194 Newsmax Inc NMAX Q1 2026 Earnings NarrowerThanExpected Loss Fuels Positive Investor Sentiment FENC Q1 2026 Earnings Narrow EPS Beat Highlights Cost Discipline Amid Revenue Discontinuity Jade Biosciences Inc JBIO Q1 2026 Earnings EPS Miss Amid Continued PreRevenue Phase EPRT Q1 2026 Earnings EPS Misses Estimates Amidst Operational Adjustments Aemetis AMTX Posts Modest Gain as Renewable Energy Stock Tests Resistance Ardent Health ARDT Edges Higher Approaching Key Resistance After Modest Gain Vistagen Therapeutics VTGN Shows Modest Gain Amid Tight Trading Range CytomX Therapeutics CTMX Holds Steady Near Resistance After 325 Gain Merlin Inc MRLN Surges 833 Testing Resistance in a HighVolume Breakout AI Stock Rally Gains Momentum as SpaceX OpenAI IPO Speculation Intensifies Salesforce Snowflake Earnings in Focus IGC Q1 2026 Earnings Narrowing Losses as Cost Discipline Drives EPS Beat Orchestra BioMed OBIO Edges Higher Navigating Key Support and Resistance Levels FTSE Russell to Accelerate Inclusion of US MegaIPOs in Indexes Chevron CVX Price Target Increased by 2 at Morgan Stanley Analyst Sentiment Suggests Modest Upside Pony AI Stock Hits 52Week Low Amid 40 YeartoDate Decline Goldman Sachs CEO David Solomon AIDriven Mass Unemployment Concerns Overblown Sees Job Growth Potential Robinhood Unveils AI Agents for Autonomous Trading and Spending A New Era for Retail Investors Regeneron REGN and Parabilis Medicines Forge 232 Billion Deal to Tackle Undruggable Protein Targets EV Resale Value Key Factors That Could Impact Your Investment